Sidebar is Loading...
Loading...
Brands
Resources
YSTV
ADVERTISEMENT
Loading...
Brands
Resources
YSTV
Accelerating Solid Targetry For Medical Isotope Production.
ARTMS Inc. is the global leader in the development of novel technologies and products for enabling the cyclotron production of the world’s most-used diagnostic imaging isotopes, including gallium-68 (68Ga), technetium‐99m (99mTc), zirconium-89 (89Zr) and copper-64 (64Cu). ARTMS’ novel solid targetry approach allows for the production of the highest activity and highest quality of clinically valuable medical isotopes available. ARTMS also partners with biotechnology and radiopharmaceutical companies to concurrently develop specific GMP medical isotopes alongside their radiopharmaceuticals during all phases of preclinical and clinical development and commercialization. In 2019, ARTMS submitted its first marketing authorization application for cyclotron produced Tc-99m. ARTMS will follow similar regulatory approaches for its next suite of products.
Legal Name
:
ARTMS Inc
Headquarters
:
Burnaby, British Columbia, Canada
Founding Date
:
2013
No. of Employees
:
21 to 40
Core Team
:
1.
Paul Schaffer
Chief Technology Officer
2.
Michael Cross
Chief Innovation Officer
3.
Steven Foster
Chair of the Board
4.
Doug Gentilcore
Chief Executive Officer
See More
Total Funding
$22.3M
Investors
:
1.
Innovate BC
2.
Deerfield
3.
GF Securities
4.
Quark Venturer
See More
Chemicea Pharmaceuticals Pvt. Ltd. is an India-based pharmaceutical company specializing in the synthesis and supply of high-purity impurity reference standards, including process impurities, degradation products, and nitrosamines. Founded in 2016 and headquartered in Navi Mumbai, the company supports global pharmaceutical and research organizations with products and services for drug development, quality control, and regulatory compliance.
Frequently Asked Questions
Chemicea Pharmaceuticals Pvt. Ltd. is an India-based pharmaceutical company specializing in the synthesis and supply of high-purity impurity reference standards, including process impurities, degradation products, and nitrosamines. Founded in 2016 and headquartered in Navi Mumbai, the company supports global pharmaceutical and research organizations with products and services for drug development, quality control, and regulatory compliance.
